SHINE Technologies Submits Drug Master File with the U.S. Food and Drug Administration for Non-Carrier-Added Lutetium-177 Chloride
- Friday, July 29, 2022, 7:17
- PR Newswire
- Add a comment
JANESVILLE, Wis., July 29, 2022 /PRNewswire/ — SHINE Technologies, LLC (SHINE), a next-generation nuclear technology company, today announced the company has submitted a Drug Master File (DMF) with the U.S. Food and Drug Administration for non-carrier-added lutetium-177 (Lu-177)…
About the Author
admin has written 20720 stories on this site.